(NPR) FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19

FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19





FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19






President Donald Trump, left, FDA Commissioner Stephen Hahn, right, and Health and Human Services Secretary Alex Azar, center, announced at a news conference on Sunday that the FDA issued emergency use authorization for convalescent plasma as a COVID-19 treatment.



Pete Marovich/Getty Images


hide caption





toggle caption




Pete Marovich/Getty Images













Coronavirus Live Updates




FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19



President Trump announced on Sunday that the FDA granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on "promising" results.